Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▼ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Arrowhead Pharmaceuticals Inc. | 21 | 2 | 5 | 0 | €26.67 | €54.98 | 106.153% |
| Alkermes plc | 16 | 2 | 2 | 0 | €25.80 | €35.01 | 35.710% |
| Chromadex Corp | 10 | 1 | 0 | 0 | €2.94 | €5.55 | 88.898% |
| Addus Homecare Corp. | 21 | 1 | 3 | 0 | €112.00 | €108.78 | -2.871% |
| Evolus Inc | 10 | 0 | 0 | 0 | €11.00 | €20.46 | 86.020% |
| MPH Health Care AG | 1 | 0 | 0 | 0 | €23.40 | - | - |
| Brainstorm Cell | 2 | 0 | 1 | 0 | €0.32 | €1.84 | 478.583% |
| Madrigal Pharmaceuticals inc. | 3 | 0 | 0 | 0 | €259.10 | €315.00 | 21.575% |
| Rockwell Medical Inc. | 1 | 0 | 0 | 0 | €1.73 | €3.00 | 73.110% |
| Krystal Biotech | 17 | 0 | 0 | 0 | €202.20 | €186.59 | -7.720% |
| Novocure Ltd | 1 | 1 | 0 | 0 | €17.20 | - | - |
| Medpace Holdings Inc | 16 | 0 | 6 | 0 | €350.40 | €418.12 | 19.327% |
| Stoke Therapeutics Inc | 17 | 1 | 2 | 0 | €13.40 | €20.55 | 53.327% |
| Iovance Biotherapeutics Inc. | 22 | 2 | 1 | 0 | €9.15 | €26.25 | 186.908% |
| Personalis Inc | 8 | 1 | 0 | 0 | €2.62 | €3.26 | 24.698% |
| Amn Healthcare Svs | 1 | 0 | 0 | 0 | €57.50 | - | - |
| XOMA Corp. | 8 | 0 | 1 | 0 | €26.60 | €68.51 | 157.553% |
| Bio-Rad Labs Inc. A | 6 | 0 | 0 | 0 | €293.20 | €417.55 | 42.410% |
| Paul Hartmann AG | 3 | 0 | 0 | 0 | €196.00 | - | - |
| Dentsply Sirona Inc. | 16 | 0 | 2 | 0 | €24.32 | €35.82 | 47.293% |
| Ensign Group Inc. | 10 | 0 | 1 | 0 | €126.00 | €123.66 | -1.854% |
| Actinium Pharmaceuticals Inc. | 3 | 0 | 1 | 0 | €7.27 | €8.50 | 16.919% |
| United Therapeutics | 24 | 0 | 3 | 0 | €310.20 | €299.42 | -3.476% |
| Incyte Corp. | 12 | 2 | 0 | 1 | €64.10 | €78.05 | 21.758% |
| Globus Medical A | 1 | 0 | 0 | 0 | €66.50 | - | - |